Aadi Biosciences

Aadi axes 80% of staff after registrational Phase II trial fails
Clinical Trials Arena
Wed, 08/21/24 - 11:36 am
Aadi Biosciences
clinical trials
layoffs
mTOR inhibitors
nab-sirolimus